{
  "id": 20727602,
  "title": "Targeting AURKA by CRISPR/SaCas9 Alters Cell Cycle Progression and Enhances Lenvatinib-Associated Reduction in Cell Viability in Hepatocellular Carcinoma: An Integrated In Silico and HepG2 in Vitro Study",
  "url": "https://urgent.news/2026/11/18/targeting-aurka-by-crispr-sacas9-alters-cell-cycle-progression-and",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-18T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.17.767223v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Hepatocellular carcinoma (HCC) presents substantial clinical concerns as a result of its high treatment resistance, frequent recurrence, and strong correlation with chronic liver diseases. Aurora kinase A (AURKA) is overexpressed in HCC correlating with poor prognosis and treatment resistance. Our bioinformatics analyses revealed that AURKA overexpression in HCC is associated with mitotic…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}